Related Experiment Video
Updated: Mar 21, 2026

Author Spotlight: Innovations in iTUG Test for Enhanced Risk Assessment and Cognitive Insights
Published on: October 25, 2024
Executive Function and Measures of Fall Risk Among People With Obesity
Xuefang Wu1, Maury A Nussbaum2, Michael L Madigan3
1Grado Department of Industrial and System Engineering, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA vvxf.wu@gmail.com.
Abstract:
This study investigated the relationship between obesity and executive function, and between executive function and fall risk (as estimated from select gait parameters). Of the 39 young adults (age = 21.3 ± 2.6 years) recruited from the local university population via email announcement, 19 were in the obese group (based upon BMI and body fat percentage) and 20 were in the nonobese comparison group. Executive function was assessed using standardized tests including the Stroop test for selective attention; Trail Making test for divided attention, visuomotor tracking, and cognitive flexibility; the Verbal Fluency test for semantic memory; and the Digit-span test for working memory. Participants performed single- and dual-task walking (walking while talking) to evaluate fall risk during gait as measured by minimum toe clearance, required coefficient of friction, stance time, and stance-time variability. The obese group had lower scores for selective attention, semantic memory, and working memory. All participants had gait changes suggestive of a higher fall risk, for example, lower minimum toe clearance, longer stance time, and increased stance variability, during dual-task walking compared with single-task walking, and executive function scores (selective attention) were associated with gait (stance-time variability) during dual-task walking. Results indicate obesity was negatively associated with executive function among young adults and could increase fall risk.
More Related Videos
Related Concept Videos
Obesity
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug Dosing: Obese Patients

